LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
9.29
-0.47 (-4.82%)
At close: Apr 28, 2026, 4:00 PM EDT
9.45
+0.16 (1.72%)
After-hours: Apr 28, 2026, 7:04 PM EDT

LENZ Therapeutics Revenue

In the year 2025, LENZ Therapeutics had annual revenue of $19.09M. LENZ Therapeutics had revenue of $1.59M in the quarter ending December 31, 2025.

Revenue (ttm)
$19.09M
Revenue Growth
n/a
P/S Ratio
15.26
Revenue / Employee
$125,579
Employees
152
Market Cap
291.28M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202519.09M--
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 202215.00M--
Dec 31, 2021---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cellectis 79.59M
Compugen 72.76M
Editas Medicine 40.52M
C4 Therapeutics 35.95M
Zentalis Pharmaceuticals 26.87M
Abeona Therapeutics 5.82M
AC Immune 4.51M
Revenue Rankings